Found 16 matching trials
Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
PHASE2The primary objective of this study is to evaluate the safety and efficacy ...
Location
UCI Center for Clinical Research
A Study of Pitolisant in Patients With Prader-Willi Syndrome
PHASE3This is a Phase 3, randomized, double-blind, placebo-controlled, multicente...
Location
Santa Monica Clinical Trials
Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)
PHASE3This is a multicentric International Phase III,Long term open label study(1...
Pitolisant in Refractory Restless Legs Syndrome
PHASE4This is an open-label trial in Restless Legs Syndrome (RLS) patients inadeq...
Location
Houston Methodist Hospital
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
PHASE3This is a Phase 3, multicenter, randomized, double-blind, parallel-group, p...
Location
Sleep Disorders Center of Alabama
A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
PHASE3The primary objective of this study is to evaluate the safety and efficacy ...
Location
Phoenix Medical Group
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
PHASE2The primary objective of this study is to evaluate the safety and efficacy ...
Location
Rady Children's Hospital - San Diego
Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
PHASE3To compare the efficacy of BF2.649 over placebo (12 week Double-Blind Phase...
Location
Klinik für Neurologie Universitätsklinikum
A Study of HBS-201 (Pitolisant Delayed-release)
PHASE1The purpose of this study is to assess the tolerability of HBS-201 when sta...
A Study of Pitolisant in Participants With Prader-Willi Syndrome
PHASE3The purpose of this study is to assess safety of pitolisant in eligible par...
Status
Enrolling By Invitation